Fármaco Uruguayo

What Fármaco Uruguayo does

Fármaco Uruguayo, operating commercially under the humanova brand, is a privately held pharmaceutical corporation that manufactures and distributes prescription and over-the-counter medications across multiple therapeutic areas. The company was founded in 1942 in Uruguay and operates a network of wholly-owned affiliates in nine countries — Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Portugal, and Uruguay — with marketing reach in 50 countries. Its portfolio spans more than 2,250 marketed products and serves approximately 2,640 clients worldwide, anchored by a 251-500 employee headcount. Recent strategic activity includes a 2026 partnership with Bayer to expand access to oncology therapies in Brazil and the launch of the Nutribén infant formula line in Peru via Medifarma Humanova.

The company generates revenue through one-time sales of pharmaceutical and nutritional products distributed via its regional affiliate offices and channel partnerships. Its go-to-market combines direct enterprise field sales to healthcare providers and institutions with channel-driven distribution through regional partners such as Medifarma in Peru. The customer segment is primarily the general population, with a horizontal segmentation approach targeting broad access to affordable pharmaceutical products across LATAM and Portugal. The company also engages in targeted social-impact initiatives, such as a partnership with Minera Lincuna to deliver advanced prosthetic technology to Peruvian Army personnel.

The head office is listed at 2665 South Bayshore Drive, Miami, Florida, while the original Uruguayan operational base remains in Montevideo. humanova® is a registered trademark, and the company maintains a compliance program including a Code of Conduct and Pharmacovigilance Policy. No revenue figures, funding rounds, acquisitions, or leadership changes are disclosed in the available source material, limiting the ability to assess financial trajectory or ownership structure beyond confirmation of private, independent status.

Name

Fármaco Uruguayo

Legal name

humanova

Website

https://fu.com.uy

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

251–500 employees

Short description

Fármaco Uruguayo (humanova) is a privately held Uruguayan-founded pharmaceutical corporation that manufactures and distributes prescription, OTC, and nutritional products through nine LATAM and Portuguese affiliates, serving roughly 2,640 clients across 50 countries with a portfolio of 2,250+ products.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

akta.pro secondary industry

Specialized Dairy Nutrition Base Powder & Premix Manufacturing (Vitamin/Mineral/Functional Premixes) (AFAHAHAJ)

Keywords

• Pharmaceutical manufacturing
• Prescription medications
• Infant nutrition
• Oncology therapies
• Over-the-counter drugs

Headquarters

HQ city

Montevideo

HQ country

Uruguay

HQ region

Latin America

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Sale of marketed pharmaceutical products across multiple therapeutic areas including oncology, infant nutrition (Nutribén), and general healthcare products. Products are distributed through affiliates and channel partners across Latin America and beyond.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Fármaco Uruguayo, part of the humanova pharmaceutical corporation, manufactures and distributes a portfolio of pharmaceutical products including prescription and over-the-counter medications, infant nutrition products (Nutribén), and oncology therapies. The company operates as a Uruguay-based affiliate within a network that distributes over 2,250 marketed products across 50 countries through regional offices and channel partners.

Product overview

humanova is a pharmaceutical corporation that operates as an integrated network of operations across multiple countries (Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Portugal, Uruguay). The company offers a diverse portfolio of over 2,250 marketed products across 50 countries, including pharmaceutical products and nutritional supplements. Notable products include Nutribén, an infant formula line, and the company maintains strategic partnerships for oncology therapies with Bayer in Brazil.

Differentiator

Problem solved

Functional benefit

Brands

• Nutribén: Infant formula line of complete and advanced nutrition designed to support growth and development of young children
• Medifarma Humanova

Products and services

• Nutribén Infant Formula Line Complete and advanced infant formula line specially designed to support the growth and development of young children; distributed in Peru through Medifarma and available across other humanova markets.
• Prescription and Over-the-Counter Pharmaceutical Products Broad portfolio of prescription and over-the-counter medications across multiple therapeutic areas, manufactured by Fármaco Uruguayo and distributed through the humanova affiliate network and channel partners across Latin America and beyond.
• Oncology Therapies Oncology therapies distributed in Brazil through a strategic partnership with Bayer, leveraging the expertise of humanova's Brazilian affiliate to expand access to cancer treatments in the Latin American market.

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core, flagship and minor.

• MedifarmacoreChannel Partner/ Reseller/ Distributor · 4 May 2026Distribution partnership for Nutribén infant formula line launch in Peru. Medifarma distributes the new line of complete and advanced nutrition products specially designed to support growth and development of young children.
• BayerflagshipStrategic or Co-development Partner · 21 April 2026Strategic partnership to expand access to oncology therapies in Brazil. The transaction leverages the expertise of Humanova's Brazilian affiliate. This is a significant partnership for expanding cancer treatment access in the Latin American market.
• Minera LincunaminorStrategic or Co-development PartnerPartnership to deliver advanced prosthetic technology to personnel of the Peruvian Army. Joint initiative between Medifarma Humanova and Minera Lincuna for social impact.

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• EMS Pharma: EMS is the largest Brazilian pharmaceutical company by units sold, with a broad generics and branded portfolio distributed across Brazil and select LATAM markets. Comparable in scale, breadth, and emerging-market focus.
• Eurofarma: Eurofarma is one of the largest Brazilian pharmaceutical companies with significant LATAM presence, operating in prescription, OTC, and hospital segments. Comparable in multi-country LATAM distribution and broad portfolio strategy.
• Megalabs: Megalabs is a LATAM-headquartered pharmaceutical company with operations across more than 15 countries, distributing branded generics, OTC, and specialty products. It is a direct comparable in scale, multi-country affiliate model, and therapeutic breadth.
• Knight Therapeutics: Knight Therapeutics specializes in in-licensing and commercializing innovative pharmaceuticals across Canada and select LATAM markets. Directly comparable in partner-led growth model and specialty pharma positioning.
• Genomma Lab: Genomma Lab is a Mexican pharmaceutical company focused on branded generics, OTC, and personal care products across LATAM. Highly comparable business model of multi-country branded-pharmaceutical distribution without heavy proprietary R&D.
• Aché Laboratórios: Aché is a major Brazilian pharmaceutical company with prescription, OTC, and dermatology lines and expanding LATAM operations. Comparable multi-country branded pharma model targeting similar institutional and retail channels.

Broad incumbents

• Bayer: Bayer is a global pharmaceutical and consumer health major and an active strategic partner of humanova in oncology. Comparable because of overlapping oncology and consumer health portfolios in LATAM, but operates at vastly larger scale.
• Sanofi: Sanofi is a global pharmaceutical company with significant LATAM presence across prescription, vaccines, and consumer health. Overlaps with humanova in multi-country branded pharma distribution but at incumbent scale with proprietary R&D.

Regional players

• Aspen Pharmacare: Aspen Pharmacare is a South African-headquartered pharmaceutical company focused on emerging markets with branded generics and specialty pharma. Comparable emerging-markets distribution focus but operates primarily outside LATAM geography.
• Grupo Farmacos: Grupo Farmacos (sometimes styled Fármacos) operates as a regional pharmaceutical distribution group in parts of Latin America. Comparable regional pharma distribution profile, though narrower geographic and portfolio footprint than humanova.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/farmaco-uruguayo

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fármaco Uruguayo